0.0700
0.0000
(0.00%)
At close: April 8 at 4:10:10 PM GMT+10
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
-2,444.0130
-2,444.0130
-6,869.1390
-3,376.7090
-1,678.2450
Financing Cash Flow
-14,001.1620
-14,001.1620
--
--
8,093.8770
End Cash Position
6,025.0680
6,025.0680
22,470.2430
29,339.3820
32,716.0910
Issuance of Capital Stock
16,250.1250
--
--
--
8,647.5470
Repurchase of Capital Stock
-14,001.1620
-14,001.1620
--
--
-553.6700
Free Cash Flow
-2,444.0130
-2,444.0130
-6,869.1390
-3,376.7090
-1,678.2450
6/30/2021 - 7/5/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NSB.AX NeuroScientific Biopharmaceuticals Limited
0.0350
0.00%
BTC.AX BTC Health Limited
0.0460
-8.00%
VBS.AX Vectus Biosystems Limited
0.0800
0.00%
ANR.AX Anatara Lifesciences Ltd
0.0060
0.00%
RNV.AX RENERVE FPO [RNV]
0.1100
+4.76%
1AI.AX Algorae Pharmaceuticals Limited
0.0060
+20.00%
TRP.AX Tissue Repair Ltd
0.2400
0.00%
BGT.AX Bio-Gene Technology Limited
0.0310
0.00%
CMB.AX Cambium Bio Limited
0.3000
+7.14%
ATX.AX Amplia Therapeutics Limited
0.0520
-1.89%